Xcout Intel
Nested Therapeutics
Nested Therapeutics is a privately held biotech company headquartered in Cambridge, Massachusetts, focused on advancing precision oncology medicine by uncovering hidden driver mutations.
Subscribe to see Nested Therapeutics’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Nested Therapeutics at a glance
Nested Therapeutics is a biotechnology company headquartered in United States. It has raised at least $125M across the 2 funding rounds on record. Its most recent funding round, Series A, raised $90M in October 2022. Xcout tracks 15 named people at Nested Therapeutics, including Darrin Miles (Chief Executive Officer).
Nested Therapeutics leadership
- Darrin MilesChief Executive Officer
- Philip KomarnitskyChief Medical Officer
- Tanja WeberChief Business Officer
- John A OrwinChairman of the Board
- Klaus Hoeflich, Ph.D.SCIENTIFIC CO-FOUNDER, ADVISOR FORMER CHIEF SCIENTIFIC OFFICER
- Arvin Dar, Ph.D.SCIENTIFIC CO-FOUNDER
9 more named people on record for Nested Therapeutics, with roles, board committees and tenure — see the full roster →
Nested Therapeutics funding rounds
At least $125M raised across the 2 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series A | $90M | 10 named | |
| Seed | $35M | 2 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Investors
Nested Therapeutics competitors
A few of Nested Therapeutics's closest competitors — see the full list of competitors and alternatives →
NextPoint Therapeutics is a private biopharmaceutical and technology company based in Cambridge, Massachusetts, focused on expanding novel therapeutic possibilities.
Tessellate Bio is a biotechnology company that develops precision oncology medicines by exploring synthetic lethal interactions beyond homologous recombination deficiency. The company integrates biomarker discovery and companion diagnostics into its research programs to create first-in-class treatments for hard-to-treat cancers.
Nido Biosciences, Inc. is a clinical-stage holding and biotechnology company headquartered in Watertown, Massachusetts. The company focuses on discovering and advancing treatments for debilitating neurological diseases, including the development of targeted drugs.
Prime Medicine, Inc. is an American biotechnology company developing gene therapies based on prime editing. The company is headquartered in Cambridge, Massachusetts.
OncXerna Therapeutics is a clinical-stage precision-oncology biotechnology company that develops RNA-based biomarkers and targeted cancer therapies. Its work is intended to help identify cancer patients most likely to benefit from particular treatments and support oncologists and pharmaceutical partners in treatment selection.
DCx Biotherapeutics is a Canadian preclinical-stage biotechnology company developing precision oncology therapeutics and precision drug conjugates to target genetically defined cancers. The company focuses on addressing root drivers and key cellular interdependencies of cancer lesions.
Get Nested Therapeutics's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Nested Therapeutics in Xcout Intel
- 15 named people with titles, LinkedIn and board committees
- 2 funding rounds with the investors in each, and who they co-invest with
- The full competitor set, tracking, exports and API access